Trials / Enrolling By Invitation
Enrolling By InvitationNCT07417774
Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- NuvOx LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this sub-study of the RESTORE trial is to identify biomarkers associated with tumor hypoxia, identify biomarkers that differentiate pseudoprogression from true progression, and correlate biomarkers with clinical outcomes.
Detailed description
Blood samples for liquid biopsy will be collected at the same time as the scheduled blood draws in the RESTORE study and analyzed by FYR Diagnostics.
Conditions
Timeline
- Start date
- 2025-12-08
- Primary completion
- 2027-12-01
- Completion
- 2030-12-01
- First posted
- 2026-02-18
- Last updated
- 2026-02-18
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07417774. Inclusion in this directory is not an endorsement.